Biolife Solutions (BLFS) Research & Development (2010 - 2026)
Biolife Solutions (BLFS) reported Research & Development of $2.6 million for Q1 2026, up 84.16% year-over-year from $1.4 million in Q1 2025, and up 4055.22% on a QoQ basis from -$67000.0 in Q4 2025.
Biolife Solutions (BLFS) has 17 years of Research & Development data on file, last reported at $2.6 million in Q1 2026.
- Quarterly Research & Development rose 84.16% year-over-year to $2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.0 million (up 94.68% YoY) and the FY2025 annual result came in at $7.6 million, up 59.25% from the prior year.
- Research & Development improved to $2.6 million in Q1 2026 per BLFS's latest filing, from -$67000.0 in the prior quarter.
- Across five years, Research & Development topped out at $4.2 million in Q1 2023 and bottomed at -$5.3 million in Q4 2023.
- The 5-year median for Research & Development is $2.6 million (2026), against an average of $1.7 million.
- The widest annual swing landed in 2023, when Research & Development slumped 167.8%; it then soared 94.62% in 2025.
- Tracing BLFS's Research & Development over 5 years: stood at -$2.0 million in 2022, then plunged by 167.8% to -$5.3 million in 2023, then soared by 76.3% to -$1.2 million in 2024, then soared by 94.62% to -$67000.0 in 2025, then surged by 4055.22% to $2.6 million in 2026.
- Per Business Quant, the three latest BLFS Research & Development figures stand at $2.6 million (Q1 2026), -$67000.0 (Q4 2025), and $2.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 361.90 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 249.00 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 94.27 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 15.80 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 189.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 44.30 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 98.66 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 139.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | - |
| 10 | Biolife Solutions | 1.20 Bn | 1.12 Bn | 17.50 Mn | 2.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.65 Mn |
| Dec 31, 2025 | -67,000.00 |
| Sep 30, 2025 | 2.71 Mn |
| Jun 30, 2025 | 2.72 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Dec 31, 2024 | -1.25 Mn |
| Sep 30, 2024 | 1.89 Mn |
| Jun 30, 2024 | 2.03 Mn |
| Mar 31, 2024 | 2.08 Mn |
| Dec 31, 2023 | -5.26 Mn |
| Sep 30, 2023 | 3.74 Mn |
| Jun 30, 2023 | 3.79 Mn |
| Mar 31, 2023 | 4.15 Mn |
| Dec 31, 2022 | -1.96 Mn |
| Sep 30, 2022 | 3.43 Mn |
| Jun 30, 2022 | 3.43 Mn |
| Mar 31, 2022 | 3.78 Mn |
| Dec 31, 2021 | 3.57 Mn |
| Sep 30, 2021 | 3.22 Mn |
| Jun 30, 2021 | 3.05 Mn |
| Mar 31, 2021 | 1.99 Mn |
| Dec 31, 2020 | 1.86 Mn |
| Sep 30, 2020 | 1.73 Mn |
| Jun 30, 2020 | 1.48 Mn |
| Mar 31, 2020 | 1.66 Mn |
| Dec 31, 2019 | 1.09 Mn |
| Sep 30, 2019 | 1.03 Mn |
| Jun 30, 2019 | 691,000.00 |
| Dec 31, 2018 | 315,000.00 |
| Sep 30, 2018 | 312,000.00 |
| Jun 30, 2018 | 325,000.00 |
| Dec 31, 2017 | 294,549.00 |
| Sep 30, 2017 | 293,093.00 |
| Jun 30, 2017 | 318,607.00 |
| Mar 31, 2017 | 286,751.00 |
| Dec 31, 2016 | 428,321.00 |
| Sep 30, 2016 | 496,874.00 |
| Jun 30, 2016 | 599,031.00 |
| Mar 31, 2016 | 504,239.00 |
| Dec 31, 2015 | 425,781.00 |
| Sep 30, 2015 | 329,527.00 |
| Jun 30, 2015 | 301,334.00 |
| Mar 31, 2015 | 322,165.00 |
| Sep 30, 2014 | 153,328.00 |
| Mar 31, 2014 | 167,287.00 |
| Jun 30, 2013 | 94,908.00 |
| Mar 31, 2013 | 105,968.00 |
| Dec 31, 2012 | 109,801.00 |
| Sep 30, 2012 | 110,689.00 |
| Jun 30, 2012 | 126,627.00 |
| Mar 31, 2012 | 116,521.00 |
| Dec 31, 2011 | 125,368.00 |
| Sep 30, 2011 | 98,903.00 |
| Jun 30, 2011 | 133,390.00 |
| Mar 31, 2011 | 158,793.00 |
| Dec 31, 2010 | 72,113.00 |
| Sep 30, 2010 | 98,350.00 |
| Jun 30, 2010 | 81,502.00 |